Skip to content
Quazepam
Doral (quazepam) is a small molecule pharmaceutical. Quazepam was first approved as Doral on 1985-12-27. It is used to treat sleep initiation and maintenance disorders in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
mental disordersD001523
Trade Name
FDA
EMA
Doral
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Quazepam
Tradename
Company
Number
Date
Products
DORALGalt PharmaceuticalsN-018708 RX1985-12-27
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
doralNew Drug Application2021-02-05
quazepamNDA authorized generic2023-02-22
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
sleep initiation and maintenance disorders—D007319F51.01
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Quazepam, Doral, Galt Pharms
76086162028-06-03U-1012
ATC Codes
N: Nervous system drugs
— N05: Psycholeptics
— N05C: Hypnotics and sedatives
— N05CD: Benzodiazepine derivative hypnotics and sedatives
— N05CD10: Quazepam
HCPCS
No data
Clinical
Clinical Trials
24 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.01234716
Cardiac arrhythmiasD001145EFO_0004269I49.91—2126
Ventricular premature complexesD018879I49.3———112
Septic shockD012772A48.3———1—1
Ventricular tachycardiaD017180I47.2———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cardiovascular diseasesD002318EFO_0000319I98——2——2
Heart diseasesD006331EFO_0003777I51.9——2——2
Myocardial infarctionD009203EFO_0000612I21——1——1
Heart arrestD006323EFO_0009492I46——1——1
Ventricular fibrillationD014693EFO_0004287I49.01——1——1
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD0138101————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameQUAZEPAM
INNquazepam
Description
Quazepam is a benzodiazepine.
Classification
Small molecule
Drug classantianxiety agents (diazepam type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
Identifiers
PDB—
CAS-ID36735-22-5
RxCUI35185
ChEMBL IDCHEMBL1200472
ChEBI ID8694
PubChem CID4999
DrugBankDB01589
UNII IDJF8V0828ZI (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 978 documents
View more details
Safety
Black-box Warning
Black-box warning for: Doral, Quazepam
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3,280 adverse events reported
View more details